Skip to main content
OpenTrials

Clinical trial condition

Stage IIB Breast Cancer

Explore clinical trials studying Stage IIB Breast Cancer. Study availability and eligibility vary by location and protocol.

45 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Stage IIB Breast Cancer trial results

Completed

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

NCT00572728

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +7 more
Locations
  • Scottsdale Medical Imaging Limited Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Morton Plant Hospital Clearwater, Florida, United States
View all 27 locations
View Trial Details
Completed

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

NCT01293032

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +18 more
Locations
  • Washington Cancer Institute Washington D.C., District of Columbia, United States
  • Carolinas Medical Center Charlotte, North Carolina, United States
  • Forsyth Regional Cancer Center Charlotte, North Carolina, United States
  • Cone Health Cancer Center Greensboro, North Carolina, United States
View Trial Details
Active, Not Recruiting

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

NCT02445391

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1024 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

NCT02957968

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Virginia Charlottesville, Virginia, United States
  • Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
View Trial Details

Related conditions